Literature DB >> 7384406

Smoking and causes of death among U.S. veterans: 16 years of observation.

E Rogot, J L Murray.   

Abstract

In a 16-year mortality followup of some 293,000 insured U.S. veterans, specific causes of death were studied in relation to smoking status. The main results confirmed earlier findings.Mortality ratios for cigarette smokers as compared with nonsmokers were 1.73 for all causes of death, 1.58 for all cardiovascular diseases, 2.12 for all cancers, and 4.31 for all respiratory diseases. The highest ratios (those greater than 5.0) were observed for cor pulmonale, aortic aneurysm, emphysema and bronchitis, cancer of the pharynx, cancer of the esophagus, cancer of the larynx, and cancer of the lung and bronchus. The greatest excess in deaths in terms of observed numbers minus expected was found for the cardiovascular diseases, in particular for coronary heart disease.Mortality ratios for ex-cigarette smokers who had stopped smoking for reasons other than physicians' orders were much lower compared with nonsmokers than the mortality ratios for current cigarette smokers: 1.21 for all causes, 1.15 for all cardiovascular diseases, 1.39 for all cancers, and 2.08 for all respiratory diseases. For most causes of death, the mortality ratios for ex-cigarette smokers who had stopped smoking for reasons other than physicians' orders varied inversely with the number of years of cessation. For some diseases, the mortality risk for the ex-cigarette smoker returned to normal almost immediately after the cessation of smoking, whereas for others, the return to normal was more gradual. The first group included stroke and the combined category of influenza and pneumonia; the second group included cardiovascular diseases as a whole and coronary heart disease. For still other diseases, although the mortality ratio declined with the length of time smoking was discontinued, substantial excess risks remained even after 20 years of cessation. In this third group were aortic aneurysm, bronchitis and emphysema, and lung cancer-diseases with very high mortality ratios for current cigarette smokers. Parkinson's disease remained the one disease that clearly exhibited a negative association with cigarette smoking.

Entities:  

Mesh:

Year:  1980        PMID: 7384406      PMCID: PMC1422715     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  8 in total

1.  Tobacco consumption and mortality from cancer and other diseases.

Authors:  H F DORN
Journal:  Public Health Rep       Date:  1959-07       Impact factor: 2.792

2.  Smoking and life expectancy among U.S. veterans.

Authors:  E Rogot
Journal:  Am J Public Health       Date:  1978-10       Impact factor: 9.308

3.  Smoking and mortality among U.S. veterans.

Authors:  E Rogot
Journal:  J Chronic Dis       Date:  1974-07

4.  A retrospective study of smoking in Parkinson's disease.

Authors:  M D Nefzger; F A Quadfasel; V C Karl
Journal:  Am J Epidemiol       Date:  1968-09       Impact factor: 4.897

5.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.

Authors:  I I Kessler; E L Diamond
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

6.  The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation.

Authors:  H A Kahn
Journal:  Natl Cancer Inst Monogr       Date:  1966-01

7.  Mortality in relation to smoking: 20 years' observations on male British doctors.

Authors:  R Doll; R Peto
Journal:  Br Med J       Date:  1976-12-25

8.  Smoking in relation to the death rates of one million men and women.

Authors:  E C Hammond
Journal:  Natl Cancer Inst Monogr       Date:  1966-01
  8 in total
  83 in total

1.  The impact of specific occupation on mortality in the U.S. National Longitudinal Mortality Study.

Authors:  N J Johnson; P D Sorlie; E Backlund
Journal:  Demography       Date:  1999-08

2.  Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation.

Authors:  A Hyland; S Garten; G A Giovino; K M Cummings
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

3.  The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer.

Authors:  Luke J Peppone; Mary E Reid; Kirsten B Moysich; Gary R Morrow; Pascal Jean-Pierre; Supriya G Mohile; Tom V Darling; Andrew Hyland
Journal:  Cancer Causes Control       Date:  2010-04-08       Impact factor: 2.506

4.  Cigarette smoking and liver cancer among US veterans.

Authors:  A W Hsing; J K McLaughlin; Z Hrubec; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

Review 5.  Differences between studies in reported relative risks associated with smoking: an overview.

Authors:  P J van de Mheen; L J Gunning-Schepers
Journal:  Public Health Rep       Date:  1996 Sep-Oct       Impact factor: 2.792

6.  Age-specific death rates with tobacco smoking and occupational activity: sensitivity to sample length, functional form, and unobserved frailty.

Authors:  J R Behrman; R C Sickles; P Taubman
Journal:  Demography       Date:  1990-05

7.  Patterns of birth cohort-specific smoking histories, 1965-2009.

Authors:  Theodore R Holford; David T Levy; Lisa A McKay; Lauren Clarke; Ben Racine; Rafael Meza; Stephanie Land; Jihyoun Jeon; Eric J Feuer
Journal:  Am J Prev Med       Date:  2014-02       Impact factor: 5.043

8.  Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults.

Authors:  M E Salive; S Satterfield; A M Ostfeld; R B Wallace; R J Havlik
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

Review 9.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

10.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.

Authors:  Michael Huncharek; K Sue Haddock; Rodney Reid; Bruce Kupelnick
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.